Cargando…

Creatine consumption and liver disease manifestations in individuals aged 12 years and over

Despite the overwhelming safety evidence concerning creatine intake in various settings, there is still incomplete information whether dietary creatine affects liver health at the population level. The main aim of this cross‐sectional population‐based study was to evaluate the association between cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Todorovic, Nikola, Korovljev, Darinka, Stajer, Valdemar, Jorga, Jagoda, Ostojic, Sergej M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922125/
https://www.ncbi.nlm.nih.gov/pubmed/36789045
http://dx.doi.org/10.1002/fsn3.3151
_version_ 1784887475068469248
author Todorovic, Nikola
Korovljev, Darinka
Stajer, Valdemar
Jorga, Jagoda
Ostojic, Sergej M.
author_facet Todorovic, Nikola
Korovljev, Darinka
Stajer, Valdemar
Jorga, Jagoda
Ostojic, Sergej M.
author_sort Todorovic, Nikola
collection PubMed
description Despite the overwhelming safety evidence concerning creatine intake in various settings, there is still incomplete information whether dietary creatine affects liver health at the population level. The main aim of this cross‐sectional population‐based study was to evaluate the association between creatine intake through regular diet and liver disease manifestations, including liver fibrosis and hepatic steatosis, among individuals aged 12 years and over, using open‐source data from the 2017–2018 U.S. National Health and Nutrition Examination Survey (NHANES). A total of 9254 male and female participants of all ages were included in the 2017–2018 NHANES round. We extracted data from the total sample population for participants who provided dietary data for individual foods via dietary interviews and examination data from liver ultrasound transient elastography. The final study sample consisted of 5957 participants (mean age 44.7 ± 21.0 years; 50.1% women), and the mean dietary creatine intake across the study population was 0.88 ± 0.71 g/day. Liver fibrosis and cirrhosis were diagnosed in 1703 (28.7%) and 288 (4.8%) participants, respectively; hepatic steatosis was identified in 2595 (43.7%) individuals. Binary logistic regression with multivariable model adjusted for age, gender, family income to poverty ratio, body mass index, total energy intake, and alcohol consumption showed that consuming more creatine (≥2 g/day) did not significantly increase the risk of liver fibrosis (OR = 0.92, 95% CI 0.70–1.21, p = .57), cirrhosis (OR = 0.94, 95% CI 0.53–1.65, p = .82), or hepatic steatosis (OR = 0.77, 95% CI 0.59–1.02, p = .07), as compared to participants who ingested <1 g of creatine daily. Dietary exposure to creatine through a regular diet is not associated with an increase in disease manifestations in individuals 12 years and over; further research is warranted to address the effects of excessive creatine intake (≥5 g/day) through a regular diet on liver health at the population level.
format Online
Article
Text
id pubmed-9922125
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99221252023-02-13 Creatine consumption and liver disease manifestations in individuals aged 12 years and over Todorovic, Nikola Korovljev, Darinka Stajer, Valdemar Jorga, Jagoda Ostojic, Sergej M. Food Sci Nutr Original Articles Despite the overwhelming safety evidence concerning creatine intake in various settings, there is still incomplete information whether dietary creatine affects liver health at the population level. The main aim of this cross‐sectional population‐based study was to evaluate the association between creatine intake through regular diet and liver disease manifestations, including liver fibrosis and hepatic steatosis, among individuals aged 12 years and over, using open‐source data from the 2017–2018 U.S. National Health and Nutrition Examination Survey (NHANES). A total of 9254 male and female participants of all ages were included in the 2017–2018 NHANES round. We extracted data from the total sample population for participants who provided dietary data for individual foods via dietary interviews and examination data from liver ultrasound transient elastography. The final study sample consisted of 5957 participants (mean age 44.7 ± 21.0 years; 50.1% women), and the mean dietary creatine intake across the study population was 0.88 ± 0.71 g/day. Liver fibrosis and cirrhosis were diagnosed in 1703 (28.7%) and 288 (4.8%) participants, respectively; hepatic steatosis was identified in 2595 (43.7%) individuals. Binary logistic regression with multivariable model adjusted for age, gender, family income to poverty ratio, body mass index, total energy intake, and alcohol consumption showed that consuming more creatine (≥2 g/day) did not significantly increase the risk of liver fibrosis (OR = 0.92, 95% CI 0.70–1.21, p = .57), cirrhosis (OR = 0.94, 95% CI 0.53–1.65, p = .82), or hepatic steatosis (OR = 0.77, 95% CI 0.59–1.02, p = .07), as compared to participants who ingested <1 g of creatine daily. Dietary exposure to creatine through a regular diet is not associated with an increase in disease manifestations in individuals 12 years and over; further research is warranted to address the effects of excessive creatine intake (≥5 g/day) through a regular diet on liver health at the population level. John Wiley and Sons Inc. 2022-11-18 /pmc/articles/PMC9922125/ /pubmed/36789045 http://dx.doi.org/10.1002/fsn3.3151 Text en © 2022 The Authors. Food Science & Nutrition published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Todorovic, Nikola
Korovljev, Darinka
Stajer, Valdemar
Jorga, Jagoda
Ostojic, Sergej M.
Creatine consumption and liver disease manifestations in individuals aged 12 years and over
title Creatine consumption and liver disease manifestations in individuals aged 12 years and over
title_full Creatine consumption and liver disease manifestations in individuals aged 12 years and over
title_fullStr Creatine consumption and liver disease manifestations in individuals aged 12 years and over
title_full_unstemmed Creatine consumption and liver disease manifestations in individuals aged 12 years and over
title_short Creatine consumption and liver disease manifestations in individuals aged 12 years and over
title_sort creatine consumption and liver disease manifestations in individuals aged 12 years and over
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922125/
https://www.ncbi.nlm.nih.gov/pubmed/36789045
http://dx.doi.org/10.1002/fsn3.3151
work_keys_str_mv AT todorovicnikola creatineconsumptionandliverdiseasemanifestationsinindividualsaged12yearsandover
AT korovljevdarinka creatineconsumptionandliverdiseasemanifestationsinindividualsaged12yearsandover
AT stajervaldemar creatineconsumptionandliverdiseasemanifestationsinindividualsaged12yearsandover
AT jorgajagoda creatineconsumptionandliverdiseasemanifestationsinindividualsaged12yearsandover
AT ostojicsergejm creatineconsumptionandliverdiseasemanifestationsinindividualsaged12yearsandover